Sparian Biosciences

Harnessing the diversity of gene processing

Sparian Biosciences is a bio-pharmaceutical company focusing on discovering and developing new therapies which target the central nervous system (CNS).

 

About

Sparian Biosciences is a bio-pharmaceutical company focusing on discovering and developing new therapies which target the central nervous system (CNS).

The treatment of CNS diseases, such as pain, addiction and psychological disorders, has seen no true pharmaceutical innovation in years.

Sparian was co-founded by Gavril Pasternak, MD PhD and Jeff Reich, MD after the Pasternak Lab discovered a novel new analgesic (e.g. pain killer) with better pain relief than morphine while minimizing the adverse side effects that cause other opioids.

Through groundbreaking research, innovative thinking and expert collaboration, our company feels we could change the way CNS diseases are treated on a global scale.

To learn more, click below

 
 

Our Team

Jeff head Shot.jpg

Introduce your team! Click here to add images, text and links, or connect data from your collection.

Chief Executive Officer

Co-founder

Jeff Reich

MD

Gav Photo.jpg

Anne Burnett Tandy Chair of Neurology

Member and Laboratory Head Molecular Pharmacology Program and Department of Neurology at MSK

 

Professor of Neurology, Neuroscience, Pharmacology and Psychiatry at Weill Cornell Medical College

Scientific and Company

Co-founder

Gavril Pasternak

MD, PhD

Pan.jpg

Attending, and Member

Department of Neurology at MSKCC

Scientific Co-Founder

Ying-Xian Pan

MD, PhD

DSC_6702.jpg

Introduce your team! Click here to add images, text and links, or connect data from your collection.

Chief Business Officer

Anna Pasternak

Sush Photo.png

Associate Professor of Pharmacology and Pharmaceutical Sciences

Center for Clinical Pharmacology

St. Louis College of Pharmacy

Washington University School of Medicine

St. Louis, MO

Scientific Co-Founder

Susruta Majumdar

PhD

Pipeline

Arylepoxamides

Arylepoxamides are a new class of drugs which have been found to bind the newly discovered AEAr receptors.

Precision Neuropsychiatry

Make this yours. Add images, text and links, or connect data from your collection.

Mitragynine Derivatives

Make this yours. Add images, text and links, or connect data from your collection.

 

© 2020 Sparian Biosciences Inc